Tocilizumab (TED) is a medicine used to treat refractory or steroid-resistant thyroid eye disease by reducing inflammation in the eye socket.
| Drug class | IL-6 Inhibitor |
|---|---|
| Type | Single |
| Forms | IV / SC |
| Common strength | 162 mg SC |
| Common Indian brands | Actemra, biosimilars |
| Prescription status | Prescription |
What Tocilizumab (TED) is used for
Tocilizumab (TED) is a specialized medicine primarily used in ophthalmology, specifically within the oculoplasty field. It is prescribed for certain complex eye conditions when other treatments may not be effective.
- Refractory/Steroid-Resistant Thyroid Eye Disease: This medicine is particularly useful for patients suffering from Thyroid Eye Disease (TED) that has not responded well to standard treatments (refractory) or for whom steroid treatments are not suitable or effective (steroid-resistant). Thyroid Eye Disease is an autoimmune condition where the immune system mistakenly attacks the tissues around the eyes, leading to inflammation, swelling, and sometimes bulging of the eyes (proptosis). Tocilizumab (TED) helps manage these severe symptoms.
How it works
Tocilizumab (TED) works by targeting a specific protein in your body called Interleukin-6 (IL-6). IL-6 is a key messenger in the immune system that plays a significant role in causing inflammation. In conditions like Thyroid Eye Disease, there is often an overactivity of this inflammatory pathway, leading to swelling and damage around the eyes.
By blocking the action of IL-6, Tocilizumab (TED) effectively reduces the inflammation in the eye socket (orbit). This reduction in inflammation helps to lessen symptoms such as swelling, pain, and the bulging of the eyes (proptosis) that are common in Thyroid Eye Disease. Essentially, it helps to calm down the overactive immune response that is causing the eye problems.
How it’s used
Tocilizumab (TED) is administered either intravenously (IV), meaning directly into a vein, or subcutaneously (SC), meaning injected under the skin. The specific method and frequency of administration will be decided by your ophthalmologist based on your individual condition and needs.
- Intravenous (IV) Administration: If prescribed as an IV infusion, it is typically given once a month. This will be done in a clinical setting, usually at the hospital or a specialized clinic, under the supervision of healthcare professionals.
- Subcutaneous (SC) Administration: If prescribed as a subcutaneous injection, it is typically given once a week. The strength for subcutaneous administration is 162 mg. Your doctor or nurse will provide detailed instructions on how to administer the injection correctly if you are to do it at home, or it may be administered by a healthcare professional.
It is crucial to follow your doctor’s instructions precisely regarding the dose, frequency, and method of administration. Do not alter your treatment schedule or stop the medicine without consulting your ophthalmologist.
Always follow your ophthalmologist’s exact instructions.
Brands available in India
- Actemra
- biosimilars
Brand availability and pricing vary; confirm with your pharmacist.
Good to know
Prescription eye medicine — use only as directed by a qualified ophthalmologist. This page is for general education and is not a substitute for professional medical advice, diagnosis or a prescription. Do not self-medicate or reuse an old prescription.
Precautions & side effects
Before starting treatment with Tocilizumab (TED), and throughout your treatment, your doctor will discuss important precautions to ensure your safety and the effectiveness of the medicine. It is vital to communicate openly with your ophthalmologist about your medical history and any concerns you may have.
- Steroid-Sparing Option: Tocilizumab (TED) can be a valuable treatment option for patients with active Thyroid Eye Disease, especially when there is a need to reduce or avoid the use of steroids (steroid-sparing). Your doctor will assess if this is the right approach for your condition.
- Infection Screening: Because Tocilizumab (TED) affects your immune system, there is a risk of infections. Before starting treatment, your doctor will conduct thorough screening for any existing infections. It is important to report any signs of infection (such as fever, chills, cough, sore throat, or unusual tiredness) to your doctor immediately during your treatment. Your doctor will monitor you closely for any signs of infection throughout your therapy.
- Prescription Medicine: Tocilizumab (TED) is a prescription medicine. It must only be used under the direct supervision and guidance of a qualified ophthalmologist. Never self-medicate or use an old prescription.
- General Health: Always inform your doctor about all your current medications, including over-the-counter drugs, supplements, and herbal remedies, as well as any other medical conditions you have.
Understanding Thyroid Eye Disease (TED)
Thyroid Eye Disease (TED), also known as Graves’ ophthalmopathy, is an autoimmune condition that affects the eyes and the tissues around them. It is often, but not always, associated with an overactive thyroid gland (hyperthyroidism), particularly Graves’ disease. In TED, your body’s immune system mistakenly attacks the healthy tissues around your eyes, including the muscles and fatty tissue behind the eyeball. This immune attack leads to inflammation, swelling, and a buildup of fluid and tissue in the eye socket.
The symptoms of TED can vary widely from person to person and can range from mild to severe. Common symptoms include a gritty sensation in the eyes, dryness, redness, puffiness around the eyes, double vision, and pain or pressure behind the eyes. A hallmark symptom is proptosis, or bulging of the eyes, which occurs due to the swelling of tissues behind the eyeball. In severe cases, TED can lead to vision problems, including blurred vision or even vision loss if the optic nerve is compressed. It’s important to understand that TED can be an active disease for a period, causing inflammation and changes, and then enter an inactive phase. Managing TED often requires a multidisciplinary approach involving endocrinologists and ophthalmologists.
General Advice for Eye Medicine Use and Hygiene
When using any eye medicine, including injections like Tocilizumab (TED), maintaining strict hygiene is paramount to prevent infections and ensure the best possible outcome. Always wash your hands thoroughly with soap and water before handling any medicine or touching your eyes. If you are administering subcutaneous injections at home, ensure the injection site is clean and follow the specific instructions provided by your healthcare professional for preparing the medicine and administering the injection. Never touch the tip of a syringe or vial with your fingers or allow it to touch any surface, as this can introduce germs.
It’s also crucial to store your medicine correctly. Keep Tocilizumab (TED) as instructed by your pharmacist or doctor, usually in a cool, dry place, and away from direct sunlight or excessive heat. Do not use medicine that has expired or appears discolored or cloudy. If you are unsure about the proper storage or administration, always ask your pharmacist or ophthalmologist. Regular follow-up appointments with your ophthalmologist are essential to monitor your progress and adjust treatment as needed. Do not share your medicine with anyone else, even if they have similar symptoms, as this medicine is specifically prescribed for your condition.
When to Seek Medical Help
While Tocilizumab (TED) is prescribed to help manage your condition, it’s important to be aware of when to seek immediate medical attention. Always contact your ophthalmologist or seek emergency care if you experience any sudden or severe changes in your vision, such as sudden vision loss, severe eye pain, or new onset of double vision. If you notice any signs of a serious allergic reaction, such as difficulty breathing, swelling of your face or throat, severe rash, or dizziness, seek emergency medical help immediately.
As Tocilizumab (TED) affects your immune system, you should also be vigilant for signs of infection. If you develop a fever, chills, persistent cough, sore throat, unusual fatigue, or any other symptoms that suggest an infection, contact your doctor right away. Prompt medical attention for infections is crucial. Additionally, if your existing eye symptoms worsen, or if you develop any new or concerning symptoms that you haven’t discussed with your doctor, do not hesitate to reach out to your ophthalmologist. Your doctor is your best resource for managing your health and ensuring your treatment is safe and effective.
Frequently asked questions
What is Tocilizumab (TED) used for?
Tocilizumab (TED) is used to treat refractory or steroid-resistant thyroid eye disease, which is an autoimmune condition causing inflammation and bulging of the eyes.
How does Tocilizumab (TED) work?
Tocilizumab (TED) works by blocking a protein called IL-6, which is involved in inflammation. By blocking IL-6, it helps to reduce the inflammation in the eye socket and lessen symptoms like swelling and eye bulging.
What are the common brands of Tocilizumab (TED) available in India?
Common brands for Tocilizumab (TED) include Actemra and various biosimilars.
How is Tocilizumab (TED) administered?
Tocilizumab (TED) can be administered either intravenously (IV) once a month or subcutaneously (SC) once a week at a strength of 162 mg.
Do I need a prescription for Tocilizumab (TED)?
Yes, Tocilizumab (TED) is a prescription medicine and must only be used as directed by a qualified ophthalmologist.
What are the key precautions to take while using Tocilizumab (TED)?
Key precautions include using it as a steroid-sparing option in active TED and undergoing infection screening, as it can affect your immune system. Always report any signs of infection to your doctor immediately.
References
- Tocilizumab for thyroid eye disease – PMC – NIH
- Intravenous Tocilizumab Shows Potential for Treating Thyroid-Associated Ophthalmopathy – American Academy of Ophthalmology
- Tocilizumab – StatPearls – NCBI Bookshelf – NIH
- Eye health – MedlinePlus (US National Library of Medicine)
- Learn about eye health – National Eye Institute (NIH)
Medically reviewed by Dr. C Jagadesh Reddy, Chief Surgeon: Cornea, Cataract and Refractive Surgery — last reviewed 2026-07-28.
This page is for general education only and is not a substitute for professional medical advice, diagnosis or treatment. Never self-medicate or reuse an old prescription. Always consult a qualified ophthalmologist before starting, changing or stopping any eye medicine.